Navigation Links
Abbott Researchers Focus on New Cutting-Edge Approaches in the,Fight Against Cancer

Scientists to Present Data on Innovative Oncology Compounds at the American Association for Cancer Research Annual Meeting

ABBOTT PARK, Ill., April 13, 2007 /PRNewswire-FirstCall/ -- For decades, scientists have looked for new therapies that target cancer. Researchers now know that cancer cells have several unique characteristics -- they require new blood vessels to deliver oxygen and nutrients (angiogenesis), they grow uncontrollably (proliferation), they travel throughout the body (metastasis), and they escape programmed cell death, a natural process by which the body rids itself of damaged or unwanted cells (apoptosis). Robust preclinical data shows that several compounds in Abbott's oncology pipeline interfere with these vital processes. Data on two of these compounds will be presented at the American Association for Cancer Research (AACR) Annual Meeting being held April 14-18 in Los Angeles.

During the meeting, scientists from independent academic institutions and Abbott will present data on Abbott's Bcl-2 family protein inhibitor (ABT-263). This compound, currently in early clinical development, corrects defects in cancer cells that allow them to escape programmed cell death. They will also present data on an investigational PARP inhibitor (ABT-888) that enhances the effectiveness of common cancer therapies that damage DNA in cancer cells.

    Presentation highlights include:


    ABT-263

    --  "ABT-263:  An orally bioavailable Bcl-2 family protein inhibitor"

        [Oral presentation, Sunday, April 15, 1 p.m., Hall A]

    --  "Pediatric preclinical testing program (PPTP) evaluation of the Bcl-2

         inhibitor ABT-263"

        [Oral presentation, Tuesday, April 17, 3:55 p.m., Room 404 A-B]


    ABT-888

    --  "The poly(ADP-ribose) polymerase (PARP) inhibitor, ABT-888 potentiates

         the antitumor activity of temozolomide in the B16F10 syngeneic

         melanoma model: Correlation with pharmacokinetic levels and a

  
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
2. Abbott Announces Positive Nine-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
3. Abbott Announces Continued Positive Results with Xience V Everolimus Eluting Coronary Stent in Spirit Clinical Trials
4. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
5. Abbotts Investigational Treatment ABT-874 Shows Positive Results in Phase II Psoriasis Study
6. Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and Effective Treatment to Reduce Risk of Stroke
7. Abbott Announces Positive Six-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent
8. Abbotts Xience V Everolimus Eluting Coronary Stent Superior to Taxus Stent in Spirit III U.S. Pivotal Clinical Trial
9. Abbott to Present New Data Across its Vascular Portfolio at the American College of Cardiologys 56th Annual Scientific Session
10. NIEHS Researchers Identify Enzyme Critical in DNA Replication
11. Stanford Researchers Find Brain Pathway of Depression in Rats
Post Your Comments:
(Date:9/1/2015)... --  Alpha Imaging LLC , a leading distributor of advanced medical ... that they have been awarded exclusive rights to represent the complete ... new territory supplements Alpha Imaging,s existing Shimadzu sales and service responsibilities ... , Indiana , Pennsylvania , ... West Virginia , Delaware and ...
(Date:9/1/2015)... Taiwan,s GNT Biotech & Medicals ... Taipei on  August 25 th  to ... drug delivery technology that uses nano-scale gold as the ... a joint press conference held by its parent company ... latest edible gold-based food and beverage partners, together with ...
(Date:9/1/2015)...   Ivenix Inc. , a medical technology ... on a $42M round of equity financing led ... CICA, Inc., Easterly Capital, Fidelity Biosciences, and SCP ... financing will support the company,s efforts to enter ... acted as the exclusive placement agent for the ...
Breaking Medicine Technology:Alpha Imaging Expands Shimadzu Territory 2GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 2GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 3GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 4GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 5Ivenix Inc. Secures $42 Million in Funding 2Ivenix Inc. Secures $42 Million in Funding 3
... Certain brain processes happen in the blink of ... made pinpointing these events virtually impossible. The advent of ... brain electrical activity measured in milliseconds, and offering the ... and diseases. Swinburne University of Technology is set to ...
... 2011 Quest Diagnostics Incorporated (NYSE: DGX ... and services, today announced the availability of its AccuType® ... response to peginterferon alpha-based therapy for hepatitis C virus ... to physicians and other healthcare providers in the U.S. ...
Cached Medicine Technology:Australian Center Readies Brain Research Program for Addition of Elekta MEG System 2Australian Center Readies Brain Research Program for Addition of Elekta MEG System 3Australian Center Readies Brain Research Program for Addition of Elekta MEG System 4Quest Diagnostics Launches Hepatitis C Virus Therapy Test Based on IL28B Gene Variants 2Quest Diagnostics Launches Hepatitis C Virus Therapy Test Based on IL28B Gene Variants 3
(Date:9/1/2015)... , ... September 02, 2015 , ... The Journal ... quality of life, in the USA ”. , As corresponding author Mr Christopher Malone ... United States. In our study, we endeavoured to better understand how migraine headaches impact ...
(Date:9/1/2015)... ... September 01, 2015 , ... ProRehab Physical Therapy , ... partnership with Apex Physical Therapy (Apex) is official as of August ... compassionate, and empathetic care to local residents from their combined eight locations throughout ...
(Date:9/1/2015)... ... September 01, 2015 , ... Celebrity hairstylist and Beauty ... “The Beauty Behind the Fashion” on Thursday, Oct. 1, at the La Valencia ... the spotlight on the collaboration between fashion and professional hair, makeup and nail design. ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... Horizon Blue ... the 50 Best Companies for Latinas in the LATINA Style 50 Report that recognizes ... , For 2015, Horizon BCBSNJ climbs from number 24 to 21 ...
(Date:9/1/2015)... ... September 01, 2015 , ... Consumers overwhelmingly prefer ... for Dermatologic Surgery, according to a new survey that also offers insight on ... Dermatologic Procedures – which reflects views on cosmetic medical treatments and ratings for ...
Breaking Medicine News(10 mins):Health News:Migraine, treatment, comorbidities, and quality of life published by Dove Medical Press 2Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 2Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 3Health News:Celebrity Hairstylist Ted Gibson Explores Fusion of Fashion and Beauty at “Beauty Behind the Fashion” at Fashion Week San Diego Proceeds to benefit THIRST Project 2Health News:Celebrity Hairstylist Ted Gibson Explores Fusion of Fashion and Beauty at “Beauty Behind the Fashion” at Fashion Week San Diego Proceeds to benefit THIRST Project 3Health News:Horizon Blue Cross Blue Shield of New Jersey Named One of the 50 Best Companies for Latinas by Latina Style Magazine 2Health News:Horizon Blue Cross Blue Shield of New Jersey Named One of the 50 Best Companies for Latinas by Latina Style Magazine 3Health News:Survey: Consumers Prefer ASDS Members 2Health News:Survey: Consumers Prefer ASDS Members 3
... can become,overwhelming by its seemingly endless challenges when it ... there is a steady upward,trend of dads or moms ... to ensure that this role reversal is a positive ... Therapists offers the,following tips for fathers or mothers who ...
... Researchers have found surprising evidence that an antidepressant ... antipsychotic (risperidone) in the alleviation of severe agitation ... that the antidepressant was associated with significantly lower ... the online American Journal of Geriatric Psychiatry (in ...
... women, breast cancer survivors reported more days of fatigue ... the October 15, 2007 issue of CANCER, a peer-reviewed ... received both chemotherapy and radiotherapy reported the most severe ... in the general population and, anecdotally, common among cancer ...
... Believe Today,s Teens Face Greater Worries ... ... The Partnership for a Drug-Free,America(R), in collaboration with MetLife Foundation, today ... play in,the lives of their grandchildren. Released today, Grandparent,s Day, the,survey ...
... Percent of Pain Care Professionals Polled during PAINWeek 2007 ... Pain Also Suffer from Insomnia, LAS VEGAS, Sept. ... and insomnia, the polled health care professionals surveyed,during PAINWeek ... will relieve the intensity of pain. Nearly 98 ...
... DTI Medical Corporation,(Pink Sheets: DTIM) announced and publicly-noticed its shareholders that ... its Board of,Directors to affect a name change. Questions regarding the ... &,Transfer Company, Inc., Draper, Utah. Notice of the intended and pending,corporate ... ...
Cached Medicine News:Health News:Stay-At-Home Parenting: How to Juggle the Responsibilities 2Health News:Antidepressant shows early promise in treating agitation and psychotic symptoms of dementia 2Health News:Chemotherapy may be culprit for fatigue in breast cancer survivors 2Health News:Survey From The Partnership and MetLife Foundation Reveals Important Role Today's Grandparents Play in Teens' Lives 2Health News:Survey From The Partnership and MetLife Foundation Reveals Important Role Today's Grandparents Play in Teens' Lives 3Health News:Survey From The Partnership and MetLife Foundation Reveals Important Role Today's Grandparents Play in Teens' Lives 4Health News:Link Between Chronic Pain and Insomnia Uncovered at PAINWeek 2007 2Health News:Link Between Chronic Pain and Insomnia Uncovered at PAINWeek 2007 3Health News:DTI Medical Corporation Announces Reverse Split and Other Corporate Developments 2
... is the least expensive of the series. It has ... central area of the cornea. The model comes with ... a picture of a patients corneal endothelium, you simply ... on the chin rest. The left side of the ...
... Orthokeratology (oprifocon A) Contact Lenses ... lenses used for orthokeratology, a ... (myopia). The patient wears these ... in the morning. During the ...
... These are rigid gas permeable contact lenses ... that temporarily corrects nearsightedness (myopia). The patient ... removes them upon wakening. During the day, ... Paragon CRT and Quadra RG contact lenses ...
... Looking for a way to help your ... cardiovascular disease? Based on the outcomes ... Counterpulsation (ECP) has improved the quality of ... perform normal activities of daily living. , ...
Medicine Products: